Ovarian Germ Cell Tumors: Rare, Treatable, and Often Missed

Ovarian germ cell tumors begin in the egg-producing cells of the ovary, and roughly 95% of them are benign. Even among the malignant ones, five-year survival is one of the strongest figures in all of ovarian cancer.

What sets ovarian germ cell tumors apart is who they affect. They appear most often in teenagers and women in their twenties, at an age when fertility is usually the pressing concern. That shapes nearly everything about how they’re managed, from the surgical approach to the conversations that need to happen before chemotherapy starts.

Here’s what to know about the types, symptoms, treatment, and outlook.

What Are Ovarian Germ Cell Tumors?

Germ cell tumors grow from the earliest building blocks of eggs. These are the primitive cells inside your ovary that give rise to eggs, long before any mature egg exists.

That starting point is what separates them from epithelial ovarian cancer, which begins in the tissue covering the ovary and makes up roughly 90% of all ovarian cancer cases.

Two numbers are worth holding onto:

• Roughly 95% of ovarian germ cell tumors are benign, meaning they are not cancer.
• Malignant ovarian germ cell tumors, the cancerous ones, make up about 5% of all ovarian cancers.  

The pathology report is what tells you which one you’re facing. Our guide to benign vs malignant ovarian tumor explains how that determination gets made and what the wording on your report actually means.

Types of Ovarian Germ Cell Tumors

Let’s dive into the differences between benign and malignant ovarian germ cell tumors.

The Benign Type

Mature cystic teratoma, almost always called a dermoid cyst, is by far the most common ovarian germ cell tumor. It forms from cells capable of becoming any kind of body tissue, which is why these cysts sometimes contain hair, fat, or even teeth.

Dermoid cysts show up most often in women between their teens and forties. Many are found by accident, during a scan ordered for something else.

Surgery removes them. No further treatment needed.

The Malignant Types

Dysgerminoma is the most common cancerous ovarian germ cell tumor, making up roughly a third of them. Between 80 and 85% of patients are under 30. It responds exceptionally well to treatment.

Immature teratoma contains underdeveloped tissue, which can come from any of the three germ layers. Pathologists focus on one kind in particular: immature nerve tissue, which is what the grade is based on. Pathologists assign it a grade of I, II, or III depending on how much of that underdeveloped tissue they see. Grade I behaves far more predictably than grade III, so the grade drives whether chemotherapy is needed.

Yolk sac tumor grows quickly. That speed cuts both ways: it also means the tumor tends to cause symptoms early, and roughly 70% are still confined to one ovary when found.

Mixed germ cell tumors contain more than one type at once, most commonly dysgerminoma together with yolk sac tumor.

Embryonal carcinoma and non-gestational choriocarcinoma are rare and fast-growing. Embryonal carcinoma almost never appears on its own in the ovary; it usually turns up as one part of a mixed tumor.

These sit alongside the other rare ovarian cancer subtypes that receive a fraction of the research attention that the most common forms of the disease gets.

Symptoms of Ovarian Germ Cell Tumors

At least 85% of patients have abdominal pain and a mass in the abdomen at diagnosis. Other signs include:

• Abdominal swelling or bloating, often without weight gain anywhere else
• Pelvic pain that doesn’t go away
• Vaginal bleeding that isn’t normal for you
• Feeling full quickly, or changes in bowel habits
• Early puberty in children, when the tumor produces certain hormones

Sudden, severe pain can mean the mass has burst or twisted, cutting off its own blood supply. That needs emergency care.

Advanced ovarian cancer is known for vague symptoms that creep up slowly. Germ cell tumors are different. They often grow fast enough that something feels clearly wrong, which is part of why so many are caught at stage I.

How Ovarian Germ Cell Tumors Are Diagnosed

Diagnosis usually moves through three steps.

Imaging. An ultrasound comes first, sometimes followed by a CT or MRI scan. A solid mass on a young woman’s ovary should prompt further testing right away.

Blood work. Germ cell tumors release proteins into the blood that can be measured. The three that matter most are AFP, hCG, and LDH. Different tumor types produce different combinations, so these ovarian cancer biomarkers help point toward a diagnosis before surgery and track how well treatment is working afterward.

Surgery and pathology. A definitive answer requires actual tissue. Because these tumors are rare and several subtypes look similar under a microscope, pathologists often use special stains to tell them apart. Having that review done by a pathologist who specializes in gynecologic cancers makes a real difference in getting the diagnosis right.

There is no screening test for ovarian germ cell tumors. One group carries a known risk: people born with a Y chromosome in their ovarian tissue, a condition called gonadal dysgenesis (also known as Swyer syndrome), can develop a tumor called a gonadoblastoma. Gonadoblastomas are benign on their own, but they frequently give rise to cancer, most often a dysgerminoma. They are sometimes offered oophorectomy surgery (or gonadectomy) to prevent it.

Treatment for Ovarian Germ Cell Tumors

Surgery is the foundation of treatment. And unlike most other ovarian cancers, fertility sparing surgery in ovarian cancer is the standard approach here, not a special request.

For most patients, that means removing the affected ovary and its fallopian tube while leaving the healthy ovary and the uterus in place. The surgeon also rinses the abdomen with fluid and sends it to the lab to check for stray cancer cells. 

If the second ovary looks normal, standard practice is to leave it alone. Biopsy is reserved for an ovary that appears abnormal, since cutting into healthy tissue carries its own risks, including scarring that can affect fertility later.

Anyone who may need chemotherapy and may want the option for children should see a fertility specialist before treatment starts. Oocyte cryopreservation, or egg freezing, is time-sensitive, and it’s an easy conversation to lose in the rush of a new diagnosis.

Chemotherapy. Surgery alone can be enough for the earliest-stage dysgerminoma and the earliest, lowest-grade immature teratoma. Most other patients receive three to four rounds of chemotherapy. 

The standard regimen is BEP: bleomycin, etoposide, and cisplatin. Carboplatin paired with etoposide is an alternative for select patients, mainly those with resected stage II or III dysgerminoma where limiting toxicity is the priority.

Germ cell tumors respond unusually well to these drugs. 85% to 95% of patients resume having periods afterward, and pregnancy outcomes are generally good.

Our guides to chemotherapy for ovarian cancer and ovarian cancer treatment side effects cover what the weeks of treatment actually look like.

Survival Rates for Ovarian Germ Cell Tumors

Reported five-year survival varies by source, since these tumors are rare and studies pull from different registries and time periods. The pattern, though, holds across all of them: outcomes are strong, and they track closely with how far the tumor has spread.

• Still inside the ovary: 98%
• Spread to nearby tissue or lymph nodes: 86% (includes Stage 1)
• Spread to distant parts of the body: 88% overall; 70% Stage III to IV progression-free survival 76%
• All stages combined: 93%

For comparison, the all-stages figure for the most common type of ovarian cancer is 44% at 5 years for overall survival (49% for epithelial ovarian cancer, per SEER data).

Stage matters most. So does who operates. A gynecologic oncologist knows how to stage these tumors correctly and how to protect fertility while doing it.

Important note: Ovarian cancer survival rates have been improving steadily over the years due to advancements in treatment. While these rates are based on large population studies and serve as a general guide, they don’t necessarily reflect individual situations and they do not definitively predict any one person’s journey with ovarian cancer. 

A gynecologic oncologist should be able to answer the patient’s questions and make a more accurate prognosis. They can also provide a more accurate assessment by taking into account personal circumstances and creating a tailored treatment plan. 

Factors such as the specific type of ovarian cancer, stage at diagnosis, overall health, and response to treatment all play a role in determining a person’s unique prognosis. With the support of a medical team and loved ones, individuals can navigate this challenging time with strength and resilience.

Follow-Up After Treatment

Monitoring is closest during the first two years, because that’s when ovarian cancer recurrence is most likely. Typical follow-up means exams and blood tests every couple of months at first, gradually spacing out over the next few years. Tumor marker testing often continues for as long as a decade.

Those blood tests earn their place. A rising AFP or hCG level can signal that cancer has returned before anything shows up on a scan.

Where Germ Cell Tumors Fit Next to LGSOC and Borderline Tumors

Ovarian germ cell tumors are biologically distinct from low-grade serous ovarian cancer and borderline ovarian tumors. Different cells of origin, different behavior, different drugs.

But they share a demographic and a structural problem. All three land disproportionately on young women. All three are rare enough that ovarian cancer clinical trials are difficult to fill, treatment guidance leans on small studies rather than large ones, and patients often meet doctors who have treated only a handful of similar cases. In all three, fertility is a central question rather than an afterthought.

Frequently Asked Questions: Ovarian Germ Cell Tumors

Are ovarian germ cell tumors cancerous? Usually not. About 95% are benign, most often dermoid cysts. The cancerous ones account for roughly 5% of all ovarian cancers.

What age do ovarian germ cell tumors affect? Most often children, teenagers, and women under 40, with cancerous cases concentrated between ages 10 and 30.

Can you still have children after an ovarian germ cell tumor? Often, yes. Surgery that removes only the affected ovary and tube is the standard approach, and 85% to 95% of patients who receive standard chemotherapy resume having periods afterward.

What blood tests are used for ovarian germ cell tumors? AFP, hCG, and LDH. Which ones are elevated varies by tumor type, and the same tests are used afterward to watch for recurrence.

Is there a screening test for ovarian germ cell tumors? No. There’s no effective screening test for the general population, which is why lasting abdominal pain, bloating, or a lump in a young woman deserves investigation rather than reassurance.

How aggressive are ovarian germ cell tumors? It varies by type. Dysgerminomas respond extremely well to treatment and carry an excellent outlook. Yolk sac tumors, embryonal carcinoma, and choriocarcinoma grow faster. Even so, chemotherapy works remarkably well across nearly all these subtypes.

The Bottom Line

Ovarian germ cell tumors are mostly benign, highly treatable when they aren’t, and compatible with having children afterward for the majority of patients. 

What matters most is getting the right specialist involved early, since a gynecologic oncologist is the person trained to stage these tumors correctly and preserve your fertility in the process. Ask questions, ask for a second opinion if anything feels rushed, and don’t let the word “tumor” convince you the outcome is already decided.